Annovis Bio, Inc.·4

Nov 25, 12:26 PM ET

Hoffman Michael B 4

4 · Annovis Bio, Inc. · Filed Nov 25, 2025

Insider Transaction Report

Form 4
Period: 2025-11-24
Transactions
  • Purchase

    Common Stock

    2025-11-24$3.85/sh+9,200$35,4202,491,228 total
  • Purchase

    Common Stock

    2025-11-24$4.13/sh+1,489$6,1502,482,028 total
  • Purchase

    Common Stock

    2025-11-24$4.14/sh+415$1,7182,491,643 total
  • Purchase

    Common Stock

    2025-11-24$4.15/sh+28,096$116,5982,519,739 total
Holdings
  • Common Stock

    (indirect: By Trust)
    223,357
Footnotes (1)
  • [F1]The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.

Documents

1 file
  • 4
    tm2532176-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT